title: The role of leukotrienes in the pathogenesis of systemic sclerosis.
abstract: Systemic sclerosis (SSc, scleroderma) is an autoimmune disease characterized by widespread vascular injury and progressive fibrosis of the skin and internal organs. SSc-related involvement of the lungs, heart, kidneys and/or the gastrointestinal system accounts for the increased mortality of scleroderma patients. Despite the progress which has recently been made in this field, the treatment of SSc is still unsatisfactory due to the low efficacy and/or high toxicity of available therapies. Leukotrienes are a family of lipid mediators synthesized from arachidonic acid in a process mediated by 5-lipoxygenase; they include leukotriene B4 and a group of cysteinyl leukotrienes: C4, D4, and E4. Leukotrienes play an important role in the regulation of all the processes vital to the pathogenesis of SSc, namely inflammation, vascular function and connective tissue remodeling. The available data suggests that an excessive synthesis of leukotrienes may contribute to the development and progression of SSc. Accordingly, blockade of leukotriene pathways appears to be a new, promising target for the treatment of SSc.
authors: Department of Rheumatology and Internal Medicine, Medical University of Bialystok, Poland.
authors: Sylwia
authors: S
authors: Chwieśko-Minarowska
authors: Krzysztof
authors: K
authors: Kowal
authors: Marek
authors: M
authors: Bielecki
authors: Otylia
authors: O
authors: Kowal-Bielecka
mesh_terms: D053898:Biosynthetic Pathways; D006801:Humans; D015289:Leukotrienes / Q000096:biosynthesis / Q000378:metabolism*; D012595:Scleroderma, Systemic / Q000209:etiology* / Q000378:metabolism*
chemical_list: D015289:Leukotrienes